Heideman DAM - Search Results

1

PCR-Free Shallow Whole Genome Sequencing for Chromosomal Copy Number Detection from Plasma of Cancer Patients Is an Efficient Alternative to the Conventional PCR-Based Approach.

Beagan JJ, Drees EEE, Stathi P, Eijk PP, Meulenbroeks L, Kessler F, Middeldorp JM, Pegtel DM, Zijlstra JM, Sie D, Heideman DAM, Thunnissen E, Smit L, de Jong D, Mouliere F, Ylstra B, Roemer MGM, van Dijk E. Beagan JJ, et al. Among authors: heideman dam. J Mol Diagn. 2021 Nov;23(11):1553-1563. doi: 10.1016/j.jmoldx.2021.08.008. Epub 2021 Aug 26. J Mol Diagn. 2021. PMID: 34454114 Free article.

2

Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicity.

Lind JS, Postmus PE, Heideman DA, Thunnissen EB, Bekers O, Smit EF. Lind JS, et al. J Thorac Oncol. 2009 Dec;4(12):1585-6. doi: 10.1097/JTO.0b013e3181bbb2b9. J Thorac Oncol. 2009. PMID: 20009914 Free article.

3

Bronchioloalveolar adenocarcinoma and pulmonary langerhans cell histiocytosis in a patient with MUTYH-associated polyposis.

von der Thüsen JH, van de Wetering MD, Westermann AM, Heideman DA, Thunnissen E. von der Thüsen JH, et al. J Clin Oncol. 2011 Mar 10;29(8):e188-90. doi: 10.1200/JCO.2010.32.1026. Epub 2010 Dec 28. J Clin Oncol. 2011. PMID: 21189386 No abstract available.

4

DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer.

van Boerdonk RA, Sutedja TG, Snijders PJ, Reinen E, Wilting SM, van de Wiel MA, Thunnissen FE, Duin S, Kooi C, Ylstra B, Meijer CJ, Meijer GA, Grünberg K, Daniels JM, Postmus PE, Smit EF, Heideman DA. van Boerdonk RA, et al. Am J Respir Crit Care Med. 2011 Oct 15;184(8):948-56. doi: 10.1164/rccm.201102-0218OC. Epub 2011 Jul 28. Am J Respir Crit Care Med. 2011. PMID: 21799074

5

EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy.

Thunnissen E, Bovée JV, Bruinsma H, van den Brule AJ, Dinjens W, Heideman DA, Meulemans E, Nederlof P, van Noesel C, Prinsen CF, Scheidel K, van de Ven PM, de Weger R, Schuuring E, Ligtenberg M. Thunnissen E, et al. J Clin Pathol. 2011 Oct;64(10):884-92. doi: 10.1136/jclinpath-2011-200163. J Clin Pathol. 2011. PMID: 21947301

6

KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.

Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E, Zwarthoff EC. Heideman DA, et al. J Mol Diagn. 2012 May-Jun;14(3):247-55. doi: 10.1016/j.jmoldx.2012.01.011. Epub 2012 Mar 14. J Mol Diagn. 2012. PMID: 22425762 Free article.

7

Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer.

Hubers AJ, Heideman DA, Herder GJ, Burgers SA, Sterk PJ, Kunst PW, Smit HJ, Postmus PE, Witte BI, Duin S, Snijders PJ, Smit EF, Thunnissen E. Hubers AJ, et al. J Clin Pathol. 2012 Jun;65(6):541-5. doi: 10.1136/jclinpath-2012-200712. Epub 2012 Mar 29. J Clin Pathol. 2012. PMID: 22461647

8

Negative NKX2-1 (TTF-1) as temporary surrogate marker for treatment selection during EGFR-mutation analysis in patients with non-small-cell lung cancer.

Vincenten J, Smit EF, Vos W, Grünberg K, Postmus PE, Heideman DA, Snijders PJ, Meijer G, Kuik J, Witte BI, Thunnissen E. Vincenten J, et al. J Thorac Oncol. 2012 Oct;7(10):1522-7. doi: 10.1097/JTO.0b013e3182635a91. J Thorac Oncol. 2012. PMID: 22982653 Free article.

9

Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma.

Thunnissen E, Boers E, Heideman DA, Grünberg K, Kuik DJ, Noorduin A, van Oosterhout M, Pronk D, Seldenrijk C, Sietsma H, Smit EF, van Suylen R, von der Thusen J, Vrugt B, Wiersma A, Witte BI, den Bakker M. Thunnissen E, et al. Virchows Arch. 2012 Dec;461(6):629-38. doi: 10.1007/s00428-012-1324-x. Epub 2012 Oct 12. Virchows Arch. 2012. PMID: 23064619

10

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation.

van Riel S, Thunnissen E, Heideman D, Smit EF, Biesma B. van Riel S, et al. Ann Oncol. 2012 Dec;23(12):3188-3189. doi: 10.1093/annonc/mds525. Epub 2012 Oct 18. Ann Oncol. 2012. PMID: 23079729 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page